Why Broad Tests Fall Short
23:11–24:05 · 54s
Rebecca explains current fungal screening’s limits—broad markers lack specificity for emerging pathogens.
23:11–24:05 · 54s
Rebecca explains current fungal screening’s limits—broad markers lack specificity for emerging pathogens.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.